935841-14-8 Usage
Description
1-(4-bromo-2,6-difluorobenzyl)pyrrolidine is a heterocyclic organic compound featuring a pyrrolidine ring attached to a benzyl group, which contains a bromine atom and two fluorine atoms. 1-(4-bromo-2,6-difluorobenzyl)pyrrolidine is known for its potential pharmacological activities, particularly in the development of antimicrobial and antiviral agents. The presence of bromine and fluorine atoms in the benzyl group enhances the compound's reactivity and biological activity, making it a valuable building block in organic synthesis. The pyrrolidine ring structure also offers a wide range of applications in medicinal chemistry and drug discovery.
Uses
Used in Pharmaceutical Synthesis:
1-(4-bromo-2,6-difluorobenzyl)pyrrolidine is used as a key intermediate in the synthesis of various pharmaceuticals for its potential pharmacological activities. 1-(4-bromo-2,6-difluorobenzyl)pyrrolidine's unique structure allows for the development of new drugs with improved efficacy and reduced side effects.
Used in Agrochemicals:
In the agrochemical industry, 1-(4-bromo-2,6-difluorobenzyl)pyrrolidine is used as a building block for the creation of novel compounds with pesticidal properties. Its reactivity and biological activity contribute to the development of more effective and environmentally friendly agrochemicals.
Used in Antimicrobial Agents:
1-(4-bromo-2,6-difluorobenzyl)pyrrolidine is utilized as a component in the development of antimicrobial agents due to its potential to combat various types of bacteria and other microorganisms. 1-(4-bromo-2,6-difluorobenzyl)pyrrolidine's structure allows for the design of targeted treatments with minimal impact on beneficial microorganisms.
Used in Antiviral Agents:
1-(4-bromo-2,6-difluorobenzyl)pyrrolidine is also used in the development of antiviral agents, where its unique structure and reactivity can be leveraged to create new drugs that effectively inhibit viral replication and reduce the spread of viral infections.
Used in Medicinal Chemistry:
1-(4-bromo-2,6-difluorobenzyl)pyrrolidine serves as a versatile building block in medicinal chemistry, enabling the design and synthesis of a wide range of therapeutic compounds with diverse applications, from pain management to the treatment of chronic diseases.
Used in Drug Discovery:
In the field of drug discovery, 1-(4-bromo-2,6-difluorobenzyl)pyrrolidine is employed as a starting material for the development of new drugs with improved pharmacological properties. Its unique structure and reactivity make it an attractive candidate for the creation of innovative therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 935841-14-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,8,4 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 935841-14:
(8*9)+(7*3)+(6*5)+(5*8)+(4*4)+(3*1)+(2*1)+(1*4)=188
188 % 10 = 8
So 935841-14-8 is a valid CAS Registry Number.
935841-14-8Relevant articles and documents
HISTAMINE-3 RECEPTOR ANTAGONISTS
-
Page/Page column 70, (2010/11/27)
This invention is directed to a compound of formula Ias defined herein, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition containing a compound of formula I, a process of preparation of a compound of formula I, a method of treatment of a disorder or condition that may be treated by antagonizing histamine H3 receptors, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above, and a method of treatment of a disorder or condition selected from the group consisting of depression, mood disorders, schizophrenia, anxiety disorders, Alzheimer's disease, attention-deficit hyperactivity disorder (ADHD), psychotic disorders, cognitive disorders, sleep disorders, obesity, dizziness, epilepsy, motion sickness, respiratory diseases, allergy, allergy- induced airway responses, allergic rhinitis, nasal congestion, allergic congestion, congestion, hypotension, cardiovascular disease, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastro- intestinal tract, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above.
